OrganiGram Holdings Inc. (OGI.TO)
CAD 2.1
(-7.89%)
CAD 2.1
(-7.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 277.81 Million CAD | 295.06% |
| 2022 | 70.32 Million CAD | 58.24% |
| 2021 | 44.44 Million CAD | 7.43% |
| 2020 | 41.36 Million CAD | -2.37% |
| 2019 | 42.36 Million CAD | 163.44% |
| 2018 | 16.08 Million CAD | 100.05% |
| 2017 | 8.03 Million CAD | 97.6% |
| 2016 | 4.06 Million CAD | 63.72% |
| 2015 | 2.48 Million CAD | 3621.89% |
| 2014 | 66.77 Thousand CAD | -82.21% |
| 2013 | 375.24 Thousand CAD | 167.72% |
| 2012 | 140.16 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 23.46 Million CAD | 3.71% |
| 2024 Q3 | 18.09 Million CAD | -18.8% |
| 2024 Q1 | 22.62 Million CAD | -14.98% |
| 2023 Q2 | 20.64 Million CAD | 4.12% |
| 2023 Q3 | 23.69 Million CAD | 14.79% |
| 2023 Q4 | 26.61 Million CAD | 12.31% |
| 2023 Q1 | 19.82 Million CAD | -3.48% |
| 2023 FY | 78.59 Million CAD | 11.77% |
| 2022 Q4 | 20.54 Million CAD | 5.75% |
| 2022 Q3 | 19.42 Million CAD | 21.27% |
| 2022 Q2 | 16.01 Million CAD | 11.76% |
| 2022 FY | 70.32 Million CAD | 58.24% |
| 2022 Q1 | 14.33 Million CAD | 4.28% |
| 2021 Q2 | 9.36 Million CAD | -3.49% |
| 2021 Q3 | 11.62 Million CAD | 24.04% |
| 2021 Q4 | 13.74 Million CAD | 18.29% |
| 2021 Q1 | 9.7 Million CAD | -10.37% |
| 2021 FY | 44.44 Million CAD | 7.43% |
| 2020 Q3 | 8.11 Million CAD | -47.0% |
| 2020 Q4 | 10.83 Million CAD | 33.44% |
| 2020 FY | 41.36 Million CAD | -2.37% |
| 2020 Q1 | 11.04 Million CAD | -31.14% |
| 2020 Q2 | 15.31 Million CAD | 38.71% |
| 2019 Q4 | 16.03 Million CAD | 44.32% |
| 2019 Q1 | 5.5 Million CAD | 29.38% |
| 2019 Q3 | 11.1 Million CAD | 14.22% |
| 2019 FY | 42.36 Million CAD | 163.44% |
| 2019 Q2 | 9.72 Million CAD | 76.84% |
| 2018 Q3 | 4.46 Million CAD | 3.78% |
| 2018 FY | 16.08 Million CAD | 100.05% |
| 2018 Q4 | 4.25 Million CAD | -4.79% |
| 2018 Q2 | 4.3 Million CAD | 40.44% |
| 2018 Q1 | 3.06 Million CAD | 4.03% |
| 2017 Q1 | 1.48 Million CAD | 13.55% |
| 2017 Q2 | 1.91 Million CAD | 28.92% |
| 2017 Q3 | 1.7 Million CAD | -10.88% |
| 2017 Q4 | 2.94 Million CAD | 72.95% |
| 2017 FY | 8.03 Million CAD | 97.6% |
| 2016 Q3 | 1.08 Million CAD | 19.99% |
| 2016 Q4 | 1.3 Million CAD | 19.73% |
| 2016 FY | 4.06 Million CAD | 63.72% |
| 2016 Q1 | 765.18 Thousand CAD | 25.01% |
| 2016 Q2 | 908.37 Thousand CAD | 18.71% |
| 2015 Q2 | 731.46 Thousand CAD | 12.95% |
| 2015 Q1 | 647.62 Thousand CAD | 244.69% |
| 2015 Q4 | 612.08 Thousand CAD | 23.91% |
| 2015 FY | 2.48 Million CAD | 3621.89% |
| 2015 Q3 | 493.97 Thousand CAD | -32.47% |
| 2014 Q4 | 187.88 Thousand CAD | 646.03% |
| 2014 Q2 | 15.69 Thousand CAD | 18.71% |
| 2014 Q1 | 13.22 Thousand CAD | 4.32% |
| 2014 FY | 66.77 Thousand CAD | -82.21% |
| 2014 Q3 | 25.18 Thousand CAD | 60.49% |
| 2013 Q2 | 58.7 Thousand CAD | -76.78% |
| 2013 Q1 | 252.8 Thousand CAD | 315.97% |
| 2013 Q3 | 2962.00 CAD | -94.95% |
| 2013 Q4 | 12.67 Thousand CAD | 327.85% |
| 2013 FY | 375.24 Thousand CAD | 167.72% |
| 2012 FY | 140.16 Thousand CAD | 0.0% |
| 2012 Q3 | 43.44 Thousand CAD | -46.39% |
| 2012 Q2 | 81.03 Thousand CAD | 1168.18% |
| 2012 Q1 | 6390.00 CAD | -31.26% |
| 2012 Q4 | 60.77 Thousand CAD | 39.9% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | 9296.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | -75.233% |
| Avicanna Inc. | 14.59 Million CAD | -1803.904% |
| Avant Brands Inc. | 5.65 Million CAD | -4809.207% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | -840.551% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | -2154.968% |
| Knight Therapeutics Inc. | 155.54 Million CAD | -78.609% |
| MediPharm Labs Corp. | 23.08 Million CAD | -1103.535% |
| Canopy Growth Corporation | 308.61 Million CAD | 9.98% |
| Willow Biosciences Inc. | 7.55 Million CAD | -3577.681% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | -589.668% |